Effect of modified Wuzi Yanzong Granule on patients with mild cognitive impairment from oxidative damage aspect

Chinese Journal of Integrative Medicine

Volumn 13, Issue 4, 2007, Pages 258-263

  Wang, Xue Mei ^a   Fu, Hong ^a   Liu, Geng Xin ^a   Zhu, Wei ^a   Li, Li ^a   Yang, Jin Xia ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

amyloid protein; Memory function; Mild cognitive impairment; Modified Wuzi Yanzong Granule; Oxidative damage

Indexed keywords

AMYLOID BETA PROTEIN; CHINESE DRUG; MALONALDEHYDE; MITOCHONDRIAL DNA; PLACEBO; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; WUZI YANZONG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; HUMAN; MALE; MEMORY; OXIDATIVE STRESS; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; AMYLOID BETA-PROTEIN; COGNITION DISORDERS; DISEASE PROGRESSION; DNA, MITOCHONDRIAL; DOUBLE-BLIND METHOD; DRUG COMPOUNDING; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; MALE; MALONDIALDEHYDE; MEMORY; MIDDLE AGED; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; PHYTOTHERAPY; PLACEBOS; SUPEROXIDE DISMUTASE;

EID: 37549059532     PISSN: 16720415     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11655-007-0258-7     Document Type: Article

References (14)

1. Zhou HW, Zhang JJ. Oxidative damage and mild cognitive impairment. For Med Sci: Neurol Neurosurg (Chin) 2004; 5(31): 468-470.
2. Huang Y, Dong Z. Oxidative stress and Alzheimer's disease. Chin J Clin Pharmacol Ther (Chin) 2005; 10(5): 485-488.
3. Fu H, Wang XM, Liu GX, et al. Study on relationship between mild cognitive impairment and oxygen free radical metabolism, acetylcholinesterase. Chin J Gerontol (Chin) 2004; 1(24): 17-18.
4. Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol 1999; 56: 303-308.
5. Xu SL, Wu ZY, Sun CH, et al. Clinical memory scale manual. Beijing: Psychological Research Institute of Chinese Academy of Medical Sciences, 1996: 27-35.
6. Wang XM, Fu H, Liu GX, et al. Clinical study on treatment of mild cognitive impairment by modified Wuzi Yanzong Granule. Chin J Integr Traditi West Med (Chin) 2004;5(24):392-395.
7. Ye N, Peng H. Current situation and prospect of mild cognitive impairment. Chin J Clin Rehabil (Chin) 2004;16(8):3111-3113.
8. Zhang MX, Xia JH. Bioenergetic and oxidative stress in neurodegenerative diseases. Life Sci Res (Chin) 2000;4(4):295-301.
9. Rinaldi P, Polidori MC, Metastasio A, et al. Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease. Neurobiol Aging 2003; 24: 915-919.
10. Mecocci P. Oxidative stress in mild cognitive impairment and Alzheimer disease: a continuum. J Alzheimer's Dis 2004;6: 159-163.
11. Frost D, Gorman PM, Yip CM, et al. Co-incorporation of A beta 40 and A beta 42 to from mixed pre-fibrillar aggregates. Eur J Biochem 2003; 270: 654-663.
12. 1-28 in Chinese adults. Chin J Clin Rehabil 2006;14(8): 65-67.
13. Zhang DP, Wang Q, Chen YB. Effect of beta-amyloid neurotoxicity in the onset of Alzheimer disease. Chin J Clin Rehabil (Chin) 2005; 25 (9): 174-175.
14. Wang LN. Research progress on mild cognitive impairment of aged people. Chin J Geriatr (Chin) 2005; 24(1):6-8.